Author

James Verco

Observed name: J. Verco

Institution: US Biotest (United States)

Observed institution: US Biotest (United States)

OpenAlex ID: A5024360455

Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac ® ) in a Rodent Model

2018 · James Verco, William Johnston, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 24

Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies

2020 · Shelagh Verco, Holly Maulhardt, et al. · Drug Delivery and Translational Research · 21

Early phase trial of intracystic injection of large surface area microparticle paclitaxel for treatment of mucinous pancreatic cysts

2022 · Mohamed Othman, Kalpesh Patel, et al. · Endoscopy International Open · 16

Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel

2023 · Neil R. Sharma, Simon K. Lo, et al. · Pancreas · 15

Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer

2019 · James Verco, William Johnston, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 15

Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer

2022 · Max Kates, Ahmed M. Mansour, et al. · The Journal of Urology · 10

S2 Improved Resection Rates in Locally Advanced Pancreatic Cancer (LAPC) Following EUS-FNI of Large Surface Area Microparticle Paclitaxel (LSAM Pac)

2021 · Neil Sharma, C Max Schmidt, et al. · The American Journal of Gastroenterology · 3

Sa1399 INTRACYSTIC INJECTION OF SUBMICRON PARTICLE PACLITAXEL (SPP) FOR THE TREATMENT OF MUCINOUS PANCREATIC CYSTIC LESIONS RESULTED IN REDUCTION IN CYST VOLUME, AN INTERIM REPORT

2020 · Mohamed O. Othman, Kalpesh Patel, et al. · Gastrointestinal Endoscopy · 3

Sa2006 EUS-GUIDED INJECTION OF INTRATUMORAL SUBMICRON PARTICLE PACLITAXEL (SPP) FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA (LAPC):PHASE 2 STUDY

2020 · Neil R. Sharma, Mohamed O. Othman, et al. · Gastrointestinal Endoscopy · 2

6 A Novel EUS-Guided Intratumoral Delivery of Submicron Particle Paclitaxel (SPP) for the Treatment of Locally Advanced Pancreatic Cancer (LA-PAC): A Prospective Safety, Tolerability and Preliminary Efficiency Study

2019 · Simon Lo, Andrew Hendifar, et al. · The American Journal of Gastroenterology · 2

69 NanoPac-2017-01 Mid-Study Report: Safety, Tolerability, and Preliminary Efficacy of Intracystic Submicron Particle Paclitaxel (SPP) for the Treatment of Mucinous Cysts

2019 · Mohamed Othman, Abdalaziz Tabash, et al. · The American Journal of Gastroenterology · 2

Sa300 TANDEM EUS-GUIDED FINE NEEDLE INJECTION OF INTRACYSTIC SUBMICRON PARTICLE PACLITAXEL (NANOPAC®) AS TREATMENT FOR BRANCH-DUCT IPMN: AN INTERIM SAFETY, PHARMACOKINETIC, AND EFFICACY ANALYSIS

2021 · Somashekar G. Krishna, Phil A. Hart, et al. · Gastroenterology · 1

Enhanced Tumor Regression and Immune Cell Infiltration by Inhaled Submicron Particle Paclitaxel in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer (NSCLC)

2019 · W. Johnston, J. Verco, et al. · American Journal of Respiratory and Critical Care Medicine

NanoPac inhalation treatment of NSCLC in a nude rat orthotopic lung cancer model.

2018 · Gere Dizerega, William Johnston, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 114

H-index: 6

I10-index: 6